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Although  fever  has  long  been  recognized  as  a  cardinal  manifestation  of 
hypersensitivity,  surprisingly  little  is known  about  the  mechanisms  by which 
antigens bring about changes in body temperature in hosts with delayed hyper- 
sensitivity (1, 2). There is a growing body of evidence that in this immunologic 
state antigen reacts with specifically sensitized lymphocytes to produce  soluble 
mediators, collectively known as lymphokines, that induce a variety of biologic 
effects, both in vivo and in vitro, such as cytotoxicity, inhibition of macrophage 
migration,  transformation  of  normal  lymphocytes,  chemotaxis,  and  others 
(3, 4).  It is not  known  whether  such  substances  are involved directly or indi- 
rectly in fevers induced  by injection  of antigen  into hosts with delayed hyper- 
sensitivity.  The  following  studies  were  designed  to  determine  if  lymphocytes 
play an essential  role in the release of endogenous pyrogen  (EP) 1 and hence in 
the  pathogenesis  of fever in  rabbits  with  delayed hypersensitivity  induced  by 
two  heterologous  proteins,  bovine  gamma  globulin  (BGG)  or  bovine  serum 
albumin (BSA) conjugated  to dinitrophenol  (DNP)  or by unconjugated  human 
serum albumin (HSA). 
Materials and Methods 
General.--Techniques to insure  that glassware, instruments, reagents,  and solutions were 
free of contaminating bacterial pyrogens have been previously reported (5). 
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1  Abbreviations used  in this paper: Ag Ab, antigen-antibody; BGG, bovine gamma globulin; 
BSA, bovine serum albumin; BSS, balanced salt solution; CFA, complete Freund's adjuvant; 
DLN, draining  lymph nodes;  DNP,  dinitrophenol;  EP,  endogenous pyrogen; HSA, human 
serum albumin; MEM,  Eagle's minimal  essential  medium;  MLN, mesenteric  lymph nodes; 
RSA, rabbit serum albumin. 
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Culture media were determined to be pyrogen-free by injection of at least 10 ml intra- 
venously into each of two or more rabbits. Housing, feeding, and selection of rabbits, both as 
donors and recipients, as well as techniques of pyrogen assay, were similar to those previously 
reported  (5).  Temperatures were taken  in  La  Jolla  with Thermistemp Telethermometers 
(YS1 Model 44; Yellow Springs Instrument Co., Yellow  Springs, Ohio)  and in New Haven 
with Foxboro rabbit scanning switch and fever recorder (The Foxboro Company, Foxboro, 
Mass.), both equipped with thermistor probes. Rabbits (New Zealand stock weighing 3.0-4.0 
kg each) were obtained from a single breeder for experiments with BGG and BSA carried out 
at La Jolla, Calif., and from several breeders for experiments with HSA carried out at New 
Haven, Conn. 
A ntigens.-- 
Bovine gamma globulin  (BGG): A single lot of B GG (Armour Pharmaceutical Co., Chicago 
Ill.) was used. Before each experiment  it was freshly dissolved in saline and immediately filtered 
through disposable filter units (0.22 #  without grid [Falcon  Plastics, Div. B-D Laboratories, 
Inc., Los Angeles, Calif.]).  Protein content, after filtration, was calculated for each experiment 
by nitrogen determination and generally varied between 4,4 and 5.8 mg/ml. 
Bovine  serum  albumin  (BSA):  A single lot was kindly supplied by Dr.  W.  O.  Weigle of 
Scripps Clinic and Research Foundation. This material was handled in the same manner as 
BGG. 
Human serum  albumin  (HSA):  Normal serum albumin USP salt-poor (250 mg/ml) was 
obtained from the American National Red Cross. This material was diluted 1 : 10 in saline or 
Eagle's minimal essential medium  (MEM)  before use as an immunogen or when added to 
tissues in vitro. 
Conjugates:  Dinitrophenol  (DNP)  was  conjugated to  BGG  and BSA according to  the 
method of Eisen et al.  (6). The number of DNP groups bound to these proteins was calcu- 
lated to be 41 and 43, respectively. 
Antigen-antibody  complexes:  Two rabbit antisera were used to precipitate antigen-antibody 
complexes or to form soluble complexes in antigen excess. Both had antibody-binding ratios 
of 3:3:1. As shown in Table II, precipitated complexes containing varying amounts of DNP- 
BGG were formed at or near equivalence; soluble complexes were formed with 3 mg of conju- 
gate  (30:1  antigen excess)  and with 4  mg of conjugate (80:1  excess).  The complexes were 
mixed with normal blood cells in either heparinized whole blood or in media containing 15% 
fresh autologous plasma. Cell  counts ranged from 1.I  to  1.9  X  l0 s leukocytes in 9-17  ml 
volumes/dose. The mixtures were shaken 60-70 rain for 3 hr at 37°C and incubated overnight 
at 37°C  without shaking. The cells were sedimented 18 hr later by centrifugation and the 
supernates were tested in rabbits for pyrogens. 
Antibody.--Serum  was obtained from ear b!eedings by arterial puncture of donor rabbits 
7-35  days after inoculation of antigens. Circulating antibody to hapten-proteln conjugates 
and to carrier proteins was detected by double diffusion  in agar. Where necessary, antibody 
was determined by quantitative precipitin techniques (7). 
Sensitization  of Donor  Rabbits.--DNP-BGG  or  DNP-BSA  conjugated  (10  mg/ml  of 
saline)  were incorporated in an equal volume of complete Freund's adjuvant  (CFA)  con- 
taining 10 mg of tubercle bacilli/ml.  2 Rabbits were anesthetized with 75 mg of intravenous 
sodium pentobarbital  ~ and inoculated with a  total dose of 10 mg of DNP-BGG/DNP-BSA 
in CFA (2.0 ml) distributed as follows: 0.2 ml in each front footpad; 0.5 ml in each hind paw; 
and 0.6 ml in four subcutaneous sites over the haunches. 
In experiments with HSA, 50 mgot HSA (2 ml of a  1 : 10 dilution) were incorporated in 2 
ml of CFA containing 6 rag of tubercle bacilli/ml. 0.15 ml of this emulsion (1.9 mg of HSA) 
2 Tubercle bacilli (H37Ra; Difco Laboratories, Detroit, Mich.). 
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was then injected into each of the four shaved footpads to give a total immunizing dosage of 
7.5 mg of HSA. 
Preparation of Tissues and Assay of Supernatant Fluids.--Donor rabbits (3-35  days after 
sensitization) were lightly anesthetized with 75-90 mg of intravenous sodium pentobarbital 
followed by 10,000 units of heparin  4 and exsanguinated by cardiac puncture. Blood was centri- 
fuged (1500 rpm for 30 min), the plasma removed, and the cellular sediment (with some 10-15 
ml of overlying plasma) resuspended to its original  volume in either Eagle's MEM without 
Ca  ++5  or Medium 199.  6 Blood from normal donors was usually pooled from two or  three 
animals and treated the same way. Cell counts showed that leukocytes ranged from 0.5  to 
1  X  107/ml. 
Draining lymph nodes (DLN) from axillary and popliteal regions, mesenteric lymph nodes 
(MLN), liver (about I0 g), and spleen were removed aseptically.  7 Cellular suspensions were 
prepared by teasing apart nodes or finely dividing liver and spleen in MEM or Hanks' bal- 
anced salt solution (BSS)  and gently pressing them through a  No. 50 tantalum gauze. The 
cells were then washed once in balanced salt solution (BSS) 8 and resuspended with 10% fresh 
rabbit serum in Eagle's MEM for tissue culture (containing Ca  ++ and Mg++). Final cell con- 
centrations of lymphocytes  were adjusted to contain 1-2 X  107/ml with dosages of 1-2 X  l0 s 
in volumes of 10-15  ml. Wet preparations of cells from DLN usually showed 5-10% large 
mononuclear forms, those from MLN,  1-3%. The other cells appeared to be small lympho- 
cytes. Dosages of 1 g of crude liver suspensions were dispersed in 10 ml of medium and calcu- 
lated to contain 0.7 X  10 s Kupffer cells, an amount sufficient to produce and detect EP. The 
resuspended cells were incubated overnight in Eagle's MEM, with individual dosages of 4-6 
mg of carrier protein (BGG, BSA, or HSA) or 3.5-5 mg of conjugate (DNP-BGG or DNP- 
BSA)  at 37°C,  in either Erlenmeyer or tissue culture flasks in an atmosphere of CO2. All 
samples (experimental and control) were routinely set up in duplicate in each experiment. 
The next morning, the cells incubated with antigen, as well as control preparations incubated 
either without antigen or with other activators, were centrifuged (1200 rpm for 20 min, and 
the supernatant fluids (10-15  ml/dose) were assayed for fever-inducing activity by injection 
into normal rabbits. In some instances, 1-2 X  10 s lymphocytes from either DLN or  MLN 
were  added  directly  to  0.5-1.0  X  l0  s  normal  blood  cells,  all  in  a  volume  of  15- 
20 ml, which, as supernate, was injected as a single dose into test rabbits. Additional heparin 
(1000 units/flask) was usually added to these preparations to prevent clotting.  All samples 
before and after incubation with antibiotics (penicillin  5 units/ml and streptomycin 5 #g/ 
ml) 9 were cultured in thioglycollate broth and, in the rare instance of bacterial contamination, 
the results were discarded. 
Other Activators.--Heat-killed,  washed staphylococci (see  reference 8)  (30:1  bacteria  to 
cells)  and old tuberculin (see reference 9)  (100 rag/dose) were occasionally used to compare 
ability of various tissues to release EP in vitro in response to both nonspecific and (in case of 
CFA-immunized donors' tissues incubated with  tuberculin)  specific  microbial stimuli  (8). 
4 Liquaemin Sodium (5000 units/ml; Organon, Inc., West Orange, N.J.). 
5 Grand Island Biological  Co., Grand Island, N.Y., or Flow Labs, Inc., Rockville, Md. 
6 Prepared in Department of Epidemiology at Yale Medical School and supplied by Dr. 
Harvey Liebhaber. 
7 On several occasions alveolar macrophages were flushed from the lungs to be used as a 
source of EP.  These cells  could not be activated by  standard nonspecific means, such as 
phagocytosis of bacteria (8), despite variations of media and times of incubation. Because of 
this, data derived from the use of alveolar macrophages are not recorded in this paper. 
s In experiments with HSA, the washing step was omitted. 
9 Penicillin-streptomycin solution (5000 units of penicillin and 5000 #g of streptomycin/ 
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Flasks with staphylococci were initially shaken (60-70 times/min) for 3 hr to promote phago- 
cytosis before being placed in a stationary incubator overnight. 
Recipients.--Normal  rabbits were used as recipients of supernates of all tissues and cells 
incubated with antigens. Because such animals become immunized and eventually respond 
with fever to repeated intravenous inoculation of antigen, they were not used for more than 
7-10  days.  Thereafter,  they  were  given only  control supernates  derived  from  suspensions 
without specific antigens. 
Skin  Tests.--Donor  animals were skin-tested at four abdominal sites with the 50 #g in 0.1 
ml of the following agents: BGG  (or BSA in animals sensitized to this antigen), DNP-BGG 
(DNP-BSA, DNP-RSA (rabbit serum albumin), and RSA. Tests were read at 6, 24, and 48 hr 
and areas of both erythema and induration were recorded. At 7 days and thereafter, character- 
istic gross  lesions of delayed hypersensitivity (erythema without induration) were regularly 
present at 24 and 48 hr after testing with carrier antigen and conjugate. At 10 days and there- 
after, Arthus reactions to conjugate (positive at 6 hr)  were  evident but did  not  develop  to 
carrier protein. Skin reactions to either DNP-RSA or RSA did not exceed 3 mm in diameter 
._ 2 
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Fro. 1.  Febrile responses of normal (N) and DNP-BGG sensitized (HS) rabbits to various 
dosages of bovine gamma globulin (BGG) and dinitrophenol-bovine gamma globulin (DNP- 
BGG). Each curve represents an average of two recipients challenged between days 14 and 
17 after sensitization (HS rabbits). A--A, N-BGG 550/~g; A- -&, HS-BGG 550pg; e-  -O, 
HS-BGG  110 #g; I--!,  N-DNP-BGG 3.16 mg;  0--0,  HS-DNP-BGG 474 pg;  El--E], 
HS-DNP-BGG 158 #g. 
RESULTS 
Role of Antibody  in the Production of Fever.-- 
Fevers induced by intravenous injection  of DiVP-BGG  and BGG in  sensitized 
rabbits:  Fig.  1 shows the responses of sensitized and normal rabbits to intra- 
venous  injection  of  two  dosages  of  DNP-BGG  and  BGG.  The  sensitized 
rabbits were inoculated  with  DNP-BGG in  CFA  14-17  days before testing. 
They  all  showed  delayed  skin  reactions  of  12-18  mm in  diameter  to  both 
immunizing and carrier antigens.  Note in  Fig.  1 that  the  onset  of fever was 
delayed for 45-60 min, a latency characteristic of febrile responses to microbial 
antigens given intravenously, such as tuberculin (9) ~nd staphylococcal filtrate 
(10),  as well as to other heterologous proteins such as BSA (11)  and HSA (12) 
in specifically sensitized recipients. The lack of fevers in normal rabbits given 
the same dosages indicates the specificity of the febrile response, as well as the 
absence of detectable contaminating bacterial endotoxins in these preparations. E.  ATKINS,  J.  D.  FELDMAN~  L.  FRANCIS,  AND  E.  ttURStt  1117 
Induction  of fever by passive transfer  of immune  sera to normal  rabbits subse- 
quently  given  antigen:  To  ascertain  the  possible  role  of  serum  antibody  in 
mediating  the  previously  demonstrated  febrile  responses  to  carrier  antigen 
(BGG)  and  the  conjugate  (DNP-BGG),  sera  of  donors,  immunized  with 
DNP-BGG or DNP-BSA in CFA, were passively transferred to normal rabbits 
by intravenous infusion. These sera contained circulating antibodies  as shown 
in Table I. 1 or 2 hr later, the recipients were injected with either conjugate or 
carrier antigen and temperatures were recorded. The results are given in Table 
I. In only one instance was a significant fever produced. After infusion of 22 ml 
of plasma into each of two normal recipients,  DNP-BGG produced a  fever of 
1°C with a characteristically delayed onset. BGG was nonpyrogenic in the other 
TABLE I 
Attempted Passive Transfer of Febrile Reactivity to Specific Antigen  with Plasma of Sensitized 
Donor Rabbits 
Donor 
N 
HS 
HS 
HS 
HS 
HS 
No.  Skin  Daif~  5  test 
1  / Arthus  I  15 
DH 
2  DH  7/8 
2  Arthus  15/22  ] 
DH 
1  Arthus  72/57 
2  DH 
2  Arthus  10/13 
DH 
Ab/ml  Vol 
(ug)  (ml/R) 
N.D.  22 
N.D.  22 
0  25 
o/o  o4O 
53/86  2  7 
257  40 
o/o[  40 
40/132  40 
Agent 
BGG 
DNP-BGG 
DNP-BGG 
BGG 
BGG 
Anat. 
3.4 
3.4 
5 
5 
BGG  5 
BSA  6 
BSA  6 
\~"  Response 
(°C)* 
1  0.0 
1  1.0 
1  0.0 
2  0.15 
3  0.1 
1  0.4 
2  0.1 
2  0.1 
* Change in temperature  (or average, where more than one recipient). 
DH  =  delayed  hypersensitivity;  HS  =  sensitized (DNP-BGG or  DNP-BSA); N  = 
normal; N.D.  =  not done (Ouchterlony positive); R =  recipient~ 
normal recipient,  although there were precipitating antibodies by Ouchterlony 
analysis to both agents. Further  trials with plasma of donors immunized with 
DNP-BGG  7-25  days before, with  and without antibodies  to carrier protein, 
were negative  except for a  single marginal  response  (0.4°C).  There  were also 
four  negative  experiments  in  normal  recipients  given  BSA  after  transfer  of 
plasma from donors immunized with DNP-BSA. 
These  data  showed  that  passive  transfer  of immune  sera  and  injection  of 
carrier antigen into the recipient were ineffective in inducing fever, despite the 
large volumes used (up to 40 ml) and the presence, in certain instances, of small 
amounts  of precipitating  antibody  to  the  carrier  antigen.  As  a  possible  ex- 
planation  of the  difference between  the negative  results  in these  experiments 
and those reported previously with passive transfer (11, 12), it should be noted 
that  both  the  route  and  interval  after  sensitization  were  chosen  to promote 1118  FEVER  ACCOMPANYING  DELAYED  HYPERSENSITIVITY 
delayed hypersensitivity rather  than  antibody formation and  that  the serum 
antibody levels were  therefore  quite  low. 
Studies in vitro of blood leukocytes from normal and sensitized  rabbits with anti- 
gen-antibody  (Ag Ab)  complexes:  In vivo, Ag Ab complexes activate cells to 
produce  circulating  EP  in  certain  hypersensitivity states  and  are  pyrogenic 
when  injected  intravenously  into  unsensitized  rabbits  (12).  In  vitro  experi- 
ments were carried out to mobilize EP from normal and sensitized blood cells 
by Ag Ab complexes. 
Ag Ab complexes were  prepared as particulate and  soluble complexes  (see 
TABLE  IX 
Production In Vilro of EP from Rabbit Blood Cells Incubated with A g A b Complexes 
(DNP-BGG-A  nti-DNP-BGG) 
Ag Ab Complex (protein R)  Mean temp. 
Form  No. R 
Ag/Ab*  Total protein*  increase:~ 
(°c) 
Ppt.  33/109/~g  142 #g  6  0.15 
Ppt.  83/274 #g  357 #g  4  0.18 
Ppt.  120/396/ag  516/ag  5  0.06 
Ppt.  300/990 #g  1.29 mg  4  0.13 
Sol.  3 mg/lO0 ,ug (30:1)  3.10 mg  4  0.35 
Sol.  4 mg/50 ,ag (80:1)  4.05 mg  4  0.26 
Staph §  2  1.15 
Blood cells  11  0.10 
(control) 
* Calculated from quantitative precipitin reaction (7). 
:~ In this and following tables, a mean fever of 0.3°C above control values is regarded as 
significant. 
§ Incubated at a ratio of 30 bacteria to 1 leukocyte. 
Ppt.  =  particulate complex; R  =  recipient; Sol.  =  soluble complex. 
Table II).  They  were  mixed with  normal  blood cells and  incubated  at 37°C 
overnight. The next morning, after centrifugation, the supernates were removed 
and  infused into normal rabbits to measure fever production. The  supernates 
were 9-17  ml volumes derived from  1.1  to 1.9  X  10 s leukocytes suspended in 
media or whole blood. This number of white cells is sufficient to release EP with 
known activators (5). Table II shows that normal blood cells were not activated 
to produce detectable EP. 
Three donor rabbits, immunized with DNP-BGG in CFA 6, 15, and 22 days 
before, were bled for plasma and blood leukocytes. In one, no antibodies were 
detected by double diffusion in agar  (see Table III). In  the  other  two,  anti- 
bodies to carrier protein were  53  and  86 ~g/ml,  respectively. To  these  latter 
two, 5 mg dosages of BGG were added to 5 ml of plasma to form Ag Ab soluble E.  ATKINS,  J.  D.  FELDMAN,  L.  FRANCIS,  AND  E.  HURSH  1119 
complexes in antigen excess, which were incubated at 37°C overnight and then 
added to aliquots of 1-2 X  l0  s normal blood leukocytes for a  second overnight 
incubation. 5 mg dosages of BGG were also incubated with aliquots of 1-2 X  10 s 
blood leukocytes (resuspended in Eagle's MEM)  from the immunized donors. 
The same procedures were carried out with BGG and both plasma and blood 
leukocytes from  the  rabbit without  detectable antibody. The  next  morning, 
supernates from the blood cells of both the normal and immunized donors were 
removed and infused into rabbits to measure production of EP. 
Table III shows that soluble Ag Ab complexes of BGG anti-BGG did not re- 
lease EP from normal blood leukocytes, whereas BGG alone did so from blood 
TABLE III 
Production In Vitro of EP from Blood Cells of Sensitized and Normal Donor Rabbits, Incubated 
with A ntigen (BGG) and Sensitized Plasma 
Time after  Ab/ml  Ag/Ab 
Donor  Sensitization  (per R) 
Mean temp. increase 
NB+ 
HSP +  BGG  HSB +  BGG 
day  (°C)* 
1  6  0  5 mg/0  0.17  0.52 
2  15  53#g  5 mg/265 #g >  60.times  0.10  0.85 
equivalence 
3  22  86 #g  5 rag/430 #g <  40 times  0.25  0.65 
equivalence 
Av.  (6 R)  0.17  0.68 
HSB-C Av. (6 R)  0.20 
* Each number is average of two recipients. 
C  =  control (without Ag); HSB  =  cells from  sensitized  donors; HSP  =  plasma from 
sensitized donors; NB  =  normal blood cells; R  =  recipient. 
See text for details. 
leukocytes of sensitized donors.  Carrier antigen,  in  the  absence of detectable 
antibody, also released EP  from  blood leukocytes of a  sensitized rabbit,  but 
not from normal blood leukocytes. The results also reveal the lack of pyrogenic 
factors in the carrier antigen. 
Role  of Lymphocytes.-- 
Production in vitro of EP by various tissues incubated with BUG or DNP-BGG: 
The  tissue source  of EP  was  investigated by incubating DNP-BGG  or BGG 
with  cell suspensions  of blood,  spleen, liver, DLN,  and  MLN.  These  tissues 
were removed from rabbits that were inoculated with  10 mg of DNP-BGG  in 
adjuvant 10-20 days before and showed delayed skin test or Arthus reactions, 
or both,  to DNP-BGG  and  BGG  (see skin tests in Materials and  Methods). 
1-2  )<  10 s leukocytes or 1 g  of liver suspension were incubated overnight in a 
volume of 10-12 ml of medium with 3-5 mg of DNP-BGG or BGG. The super- 1120  FEVER ACCOMPANYING DELAYED HYPERSENSITIVITY 
nates were removed by centrifugation and injected intravenously  into unsensi- 
tized rabbits and assayed for presence of EP. 
The mean febrile response of groups of rabbits to the supernatants of both 
sensitized and normal tissues incubated with various agents in vitro is shown in 
Table IV and Fig. 2. Blood leukocytes, spleen, and DLN from sensitized donors 
were capable of  generating EP  in vitro when incubated with  either BGG or 
DNP-BGG. Cells from the same sources of normal rabbits did not produce EP 
when incubated with antigen. The specificity of  the  response can be seen by 
TABLE  IV 
Production  In Vitro of EP by Various  Tissues of DNP-BGG-Sensitized  (HS) and Normal (N) 
Rabbits  Incubaled  with Antigens and  other Activating  Agents 
BGG  DNP BGG  BSA  OT*  Staph  Control:~ 
°C§  °C  °C  °C  °C  °C 
Blood ceils from:  HS  0.45  0.31  0.05  0.77  1.15  0.07 
N  0.12  0.05  0.06  0.35  0.05 
Spleen cells from:  HS  0.52  0.63  0.17  0.63][  0.98  0.24 
N  0.15  0.05  0.11  0.14 
DLN cells at:  10-14¶  0.57  0.64  0.30  0.77  0.28 
15~5¶  0.12  0.13  0.11  0.12  0.11 
MLN cells from:  HS  0.06  0.0011  0.25 
N  0.11  0.11 
Liver  HS  0.11  0.13  0.05  0.431[  0.73  0.14 
* Test rabbits immunized with complete Freund's adjuvant. 
~C No antigen or other activating agents used. 
§ Increase in temperatures are averages of four to eight recipient rabbits, except as noted 
and for "Blood" where averages are of 10 to 15 recipient rabbits. 
]/Two recipients only. 
¶ Days after sensitization. 
In this and following tables, italicized responses are considered significant (see Table II). 
lack of EP release from the sensitized tissues when incubated with a heterolo- 
gous antigen, BSA. The MLN and liver from sensitized donors, on the other 
hand, were inactive after incubation with specific antigen. Since the liver re- 
leased EP when incubated with an indifferent activator, heat-killed staphylo- 
cocci, the difference in this case was not due to a lack of pyrogen-producing  cells. 
In the  initial experiment tissues were used from donor rabbits 10-20 days 
after sensitization, as there appeared  to be no precipitating antibodies to the 
carrier  protein BGG  during this  interval. However,  when  larger  wells  were 
used for Ouchterlony analysis, precipitating antibodies were found to be present 
to BGG as well as to DNP-RGG at this stage. E.  ATKINS,  J.  D.  FELDlVIAN, L.  FRANCIS,  AND  E.  ItURSI-I  1121 
Because of this finding, further experiments with the same tissues were carried 
out at both earlier and later periods after sensitization of the donor rabbits. The 
production of EP by these tissues incubated with BGG (and, in analogous ex- 
periments,  with  BSA  in  rabbits  specifically  sensitized  to  this  antigen),  are 
shown in Table V, which incorporates the results of the earlier experiments for 
the intermediate period of 10-20 days after sensitization. 
From this table, it is apparent that no tissues were activated to produce EP 
at  1 wk after sensitization,  when  there was delayed hypersensitivity only to 
BGG by skin  test and no detectable antibody by Ouchterlony analysis,  and 
that after 3 wk, when circulating antibody was present, there was significantly 
less EP production by blood, spleen, and DLN which had been previously shown 
to be active from 10 to 20 days. 
1.0- 
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Fro. 2.  Febrile  responses of normal rabbits to endogenous pyrogen released in vitro by 
sensitized tissues (DNP-BGG-immunized donors) incubated with 5 mg dosages of BGG in 
vitro. See text for details. Each curve represents an average of two recipients. ~- -J, blood; 
0--Q, liver; ~--~, spleen; O--O, DLN;  El--[], MLN. 
P~oduction in vitro of EP from normal blood cells by interaction of antigen and 
sensitized lymphoid cells: Tissues that produced EP in vitro in the presence of 
antigen  contain  both ]ymphocytes and pyrogen-producing cells  (granulocytes 
or monocytes). MLN and liver, on the other hand, are composed, respectively, 
almost entirely of lymphocytes or of a  mixture of pyrogen-producing Kupffer 
cells and inactive hepatocytes (13). To test the hypothesis that the production 
of EP by blood, spleen, and DLN was dependent upon the presence of sensitized 
lymphocytes capable of activating pyrogen-producing cells, BGG was incubated 
overnight with a mixture nof normal blood cells and 3/ILN lymphocytes from 
either normal donors or donors sensitized 14-20 days previously. Appropriate 
controls were prepared  consisting  of blood cells incubated  with lymphocytes 
alone, as well as both blood and lymphocytes incubated with and without anti- 
gen.  After  incubation,  the  cells were  centrifuged  and  the  supernatant  fluids 
compared for release of EP by intravenous injection into normal rabbits. The 
results are shown in Table VI. Incubation of the carrier antigen BGG with a 
mixture  of sensitized  MLN  lymphocytes and  normal  blood  cells  resulted  in 1122  FEVER ACCOMPANYING DELAYED HYPERSENSITIVITY 
significant fever,  average 0.SI°C, as compared with an average fever of only 
0.29°C when lymphocytes of normal MLN were substituted for those from a 
sensitized donor. Since BGG incubated with either normal blood cells or sensi- 
tized MLN lymphocytes alone did not release detectable amounts of  EP,  the 
results suggested that specific antigen caused MLN cells to release a nonpyro- 
genic intermediate agent that activated normal blood cells. 
Supernates of BGG and DLN cells from donors 1 wk after sensitization did 
not produce fever in recipient rabbits.  1° This tissue might therefore  supply a 
TABLE  V 
Productionln Vitro ~  EPby ~ssuesqfSensitized Rabbits, Incubated withAnt~en* 
Cell source¢ 
Days after sensitization  of donor 
6-8§  lo-2o!  21-35¶ 
Blood  0/5**  7//12  2/6 
Spleen  0/5  3/7  1/5 
Liver  0/3  1/11  0/6 
DLN  0/5  3/6,+;  0/10~:~ 
MLN  0/3  0/10  0/6 
* Rabbits immunized with DNP-BGG or DNP-BSA in CFA. 
Cell suspensions were incubated with antigen overnight at 37°C, and supernatants were 
removed and injected into test rabbits. 
§ Positive delayed skin tests to carrier antigen; no antibody detected. 
I[ Positive immediate and delayed skin tests to carrier antigen; antibody in circulation of 
all donors. 
¶ Positive immediate skin tests to carrier antigen; antibody in circulation of all donors. 
** Number positive/total number. Each number represents a single experiment in which 
the average of two responses both with and without antigen are compared. 
:~:~ Numbers are for 10-14 and 15-35 days, respectively. 
Positive =  average increase in febrile response of 0.3°C or more to supernates from tissues 
incubated with antigen as compared with tissues incubated alone. BGG was used for the two 
right columns; BGG or BSA for 6-8 day column. 
source of  activated lymphocytes at this time without associated pyrogen-pro- 
ducing cells that would obscure the release of EP from normal blood cells by 
sensitized lymphocytes and antigens. 
Accordingly, suspensions of lymphocytes from both DLN and MLN of donor 
rabbits sensitized 7 or 8 days previously either with DNP-BGG or DNP-BSA 
were added with and without specific carrier antigen to normal blood cells and 
incubated overnight, as previously. The results are shown in Table VII. There 
was significant release of EP from the samples containing DLN, whereas those 
10 Supernates derived from incubation of lymphocytes of sensitized donors and antigen are 
incapable of eliciting fever in recipient rabbits within 2 hr of infusion. Such supernates were 
capable of releasing EP from normal blood leukocytes in vitro  after  18 or more hr of in- 
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with MLN from the same sensitized donors were inactive at this early period. 
EP was released from normal blood cells  by DLN incubated with or without 
antigen. Since antigen was presumed to be present in the DLN at this time (14), 
it was inferred that the marked EP release  in the control preparations was the 
result of activation of the lymphocytes by antigen (or other sensitizing agents 
such as Freund's adjuvant) absorbed from the site of inoculation. 
These results demonstrating the difference  in the capacity of DLN and MLN 
(1 wk after immunization)  to activate normal blood cells were confirmed with 
another antigen,  HSA,  in  a  larger  series  of experiments  that  included donor 
rabbits from the 3rd to 7th day after sensitization to this antigen. As evident in 
TABLE VI 
Production In Vitro of EP by Normal Blood Cdls Incubated with MLN of Sensitized or Normal 
Donors, with and without Antigen* 
No. of  Normal  Sensitized  Normal 
blood  MLN  MLN  Ag  Mean temp. increase 
trials  cells  cells  cells 
(°C) 
9  +:~  -b  BGG  0.81~ 
9  -b  -b  None  0.45~P  =  <0.01 
8  -J-  q-  BGG  0.29  jP  ~/x 
<0.01 
8  -J-  q-  None  0.18 
12  q-  BGG  0.12 
10  +  BGG  0.06 
9  q-  BGG  0.11 
* MLN removed 14-20 days after immunization. 
~; In this and following tables, each -k indicates presence of specified cells in the incuba- 
tion mixture. 
Table VIII, nearly all samples of normal blood incubated with sensitized DLN 
and antigen evoked release  of EP, whereas only one-half those incubated with 
MLN plus antigen were positive. In addition, in this larger series,  there was a 
significant increase in pyrogen release  from the samples of DLN incubated with 
antigen  as  compared  with  controls  incubated  with  sensitized  DLN  without 
antigen. 
Produclion in vitro of EP from normal blood cells by interation of viable lympho- 
cytes and antigen:  A series of experiments was devised to determine the role of 
viability of lymphocytes in activating normal blood cells to release  EP. It was 
essential  to  exclude  the  possibility  that  nonspecific activators,  e.g.  Freund's 
adjuvant  or  Gram-negative  bacterial  endotoxiu  absorbed  from  the  site  of 
inoculation, might induce EP release. 
DLN were removed from rabbits on either the 3rd or 5th day after sensitiza- 
tion  with  HSA and  one-half of the  cells  from each  node were  freeze-thawed 1124  FEVER  ACCOMPANYING  DELAYED  HYPERSENSITIVITY 
TABLE  VII 
Production In  Vitro of EP by Normal Blood Cells  Incubated with Specifically Sensitized Cells 
of DLN or MLN with and without Antigen* 
Normal  Mean 
blood ceils  DLN  MLN  Ag  temp. increase 
(°C) 
+~  +  BGG  0.90§ 
+  +  None  0.80 
+  +  BSA  0.64 
+  +  None  O. 63 
+  +  BGG  0.28 
+  +  None  0.23 
+  +  BSA  0.36 
+  +  None  0.26 
+  BGG/BSA  0.19  x 
+  BGG  0.21 
+  BSA  0.16 
+  None  0.16  × 
* DLN and MLN removed 7 or 8 days after immunization. 
Each +  indicates presence of specified cells in incubation mixture. 
§ Each number represents the mean of temperature increase in four rabbits except those 
marked x where the numbers are means of eight rabbits. 
TABLE  VIII 
Production In Vitro of EP by Normal Blood Leukoeytes Incubated with Sensitized Lymphocytes 
from DLN or MLN with and without Antigen (+HSA /C) 
Normal blood cells + 
Day  DLN  MLN  (r) HS) 
+  HSA  +  HSA >  Control  +  HSA  +  HSA >  Control 
3  4/6*  2/65  --  -- 
5  4/5  2/5  1/5  0/5 
6  5/5  4/5  3/5  2/5 
7  5/5  3/5  3/5  3/5 
Total  (5-7 days)  14/15  9/15  7/15  5/15 
Normal blood cells + 
DLN +  HSA  >  MLN  +  HSA  9/15 
DLN +  HSA  >  DLN Control  9/15 
MLN  +  HSA  >  MLN Control  5/15 
(P  =  <0,02) 
* Number positive/total number. Each number represents a  single  experiment  in which 
two responses are averaged. Positive: average febrile response (tissues +  HSA) of 0.5 +  oC. 
:~ Positive: average increase in febrile response (tissues +  HSA vs. control)  of 0.3  +  °C. 
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three times before addition to a  sample of normal blood. The other half of the 
cells were mixed with a  similar sample of blood from the same donor. Antigen 
was added in 5 mg doses to one-half of each sample  (containing intact or dis- 
rupted lymphocytes) at the time when these cells were incubated with normal 
blood cells. The remaining mixtures received no antigen. 
The results in Table IX are expressed,  as before, as the  number of positive 
over  total  number  of responses  (each  number  determined  from  the  average 
fever of two recipients in a  single experiment).  The data  clearly show that at 
this interval after sensitization,  intact lymphocytes are essential  to release EP 
TABLE IX 
Production In  Vitro of EP by Normal Blood Leukocytes Incubated with Viable or Disrupted 
DLN Cells* and with or without Antigen  (+ liSA/Control) 
Normal blood ceils + 
Viable DLN  Disrupted DLN 
+  HSA  Control  +  HSA  Control 
7/10,  4/10  1/10  2/9 
Both neg.  3/10  6/9 
Both pos.  4/10  0/9 
HSA >  control  4/10  1/9 
Control  >  HSA  1/10  2/9 
Total positive§  11/20  3/19 
Controls: viable cells (without blood)  Controls: disrupted  cells (without blood) 
(°c)  (°c) 
DLN +  HSA  0.16  (8)  DLN +  HSA  0.10  (8) 
DLN -- control  0.21  (7)  DLN -- control  0.13  (7) 
* DLN cells were removed 3 or 5 days after sensitization. 
:~ Number positive/total number  (see Table VIII). 
§ Total positive (viable vs. disrupted) : P  =  <0.01. 
Number in parentheses  =  number of experiments (two recipients each). 
from normal blood cells (total positive 11/20 vs. 3/19 for disrupted cells). Since 
in none of the three positive instances with disrupted  cells  (one with antigen, 
two control) were both the antigen and control s~mple p~sitive in the same ex- 
periment,  there  seems  little  likelihood  that  nonspecific  activators  associated 
with or ingested by the cells are responsible for the release of EP from the blood 
cells. 
Production in vitro of EP from normal blood cells by supemates of DLN lympho- 
cytes incubated with antigen:  To ascertain whether lymphocytes liberate  solu- 
ble  agents  to produce  EP  from blood  leukocytes, or whether  the presence of 
viable cells was necessary, suspensions of lymphocytes derived from DLN, both 
intact  and disrupted by freeze-thawing,  and from MLN were incubated over- 
night with and without antigen. The next day the suspensions were centrifuged 1126  ~FEVER ACCOMPANYING DELAYED HYPERSENSITIVITY 
and the supernatant fluids were added to centrifuged cell buttons derived from 
equivalent volumes of a single pooled sample of normal blood. Euch sample was 
then mixed by pipetting and allowed to incubate for 18 hr. At the end of this 
period all samples were cleared by centrifugation,  and  the supernatant fluids 
were assayed for pyrogenicity as previously. The first of these experiments tested 
supernates from DLN and MLN, incubated with antigen, and then further incu- 
bated with normal  blood cells. The  results are presented in Table X.  Super- 
notes of DLN cells and antigen released significant quantities of EP from blood 
leukocytes, while supernates of MLN cells and antigen released only barely de- 
"FABLE X 
Production In  Vitro of EP by Normal Blood Cells Incubated with Supernates of DLN or MLN 
Cells, with and without Antigen* 
Normal  Supernates of  Mean 
blood cells  DLN cells  MLN cells  Ag  temp. increase 
+I 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
(°C) 
HSA  1.10 
None  O. 40 
q-  HSA  0.18 
q-  None  0.10 
HSA  0.15 
None  0.10 
HSA  0.10 
None  0.05 
+  HSA  O. 05 
q-  None  0.08 
* DLN and MLN ceils were removed  7 days after immunization and incubated with or 
without antigen. Supernates were removed 18 hr later and incubated with normal blood cells 
or infused directly into recipient rabbits. All numbers  are averages of two values of a single 
experiment. 
:~ q- indicates presence of specified cells or supernates of cells in incubation mixtures. 
tectable EP. In other experiments of similar design, supernates of DLN, viable 
or disrupted, with  and  without  antigen, were  further  incubated with normal 
blood cells to release EP. Table XI shows these and other data derived from cells 
of donors 5--7  days after sensitization. Supernatant fluids of viable sensitized 
DLN  lymphocytes activated normal  blood leukocytes to  produce  significant 
amounts of EP, whereas those derived from disrupted DLN lymphocytes were 
uniformly inactive. In addition, supernates of viable DLN  lymphocytes incu- 
bated with antigen produced slightly higher fevers than did those from cells in- 
cubated without antigen. The results with supernates of viable MLN cells were 
intermediate, the average fever being only half  that  of  the  viable DLN,  but 
higher than those from freeze-thawed cells. 
The evolution of this capacity of sensitized lymphocytes plus antigen to acti- E.  ATKINS,  J.  D.  FELDMAN,  L.  FRANCIS,  AND  E.  HURSIt  1127 
vate normal leukocytes is shown in Table XII. This table comprises representa- 
tive experiments demonstrating pyrogen release from normal blood cells incu- 
bated with lymphocytes from DLN and MLN (both viable cells and supernatant 
fluids of viable cells previously incubated with and without antigen). From these 
data, taken at various intervals after immunization, it is apparent that lympho- 
cytes of DLN only released EP from normal blood leukocytes in the  1st wk. 
TABLE XI 
Production  In  Vitro  of EP by Normal  Blood Cells Incubated  with Supernates  of Viable or 
Disrupted DLN Cells or Viable MLN Calls* 
Supernates of 
No. oi  Normal 
trials  blood cells  DLN  DLN  MLN  Ag  Mean temp. increase 
viable  disrupted  viable 
16  +,  + 
16  +  + 
8  +  + 
8  +  + 
6  + 
6  + 
16  + 
16  + 
8  + 
8  + 
(°C) 
HSA  O. 62-....,p 
None  0.4P~---  <0.01 
i 
HSA  0. l~p 
None  0.1  <0.01 
+  HSA  0.36 
+  None  0.26 
HSA  0.23 
None  0.24 
HSA  0.09 
None  0.12 
+  HSA  0.08 
+  None  0.10 
* DLN and MLN cells were removed 5-7 days after immunization and were incubated 
with or without antigen before supernate was removed. 
See Table X. 
Thereafter, both cells and supernates of previously incubated MLN became al- 
most equally effective in mobilizing EP from unsensitized blood cells. 
DISCUSSION 
These studies demonstrate that normal blood cells, when incubated with anti- 
gen and viable sensitized lymphocytes, release EP in vitro. Since antigen alone, 
normal lymphocytes, or disrupted, sensitized cells, with or without antigen, were 
only weakly or rarely effective in this system,  the  activator appears to be a 
product of viable, sensitized lymphocytes and not a nonspecific factor (such as 1128  FEVER  ACCOMPANYING  DELAYED  HYPERSENSITIVITY 
bacterial endotoxin) associated with such cells, n On occasion normal blood ceils 
release EP in vitro when incubated with viable sensitized lymphocytes without 
antigen.  In  most  instances,  addition  of  antigen  significantly  increased  the 
effectiveness of specifically sensitized lymphocytes in activating normal blood 
leukocytes, thereby providing evidence that the reaction was, to some degree at 
least a specific one. The ability of such cells alone to activate leukocytes may be 
due to the presence of antigen in the node, a finding which has been demon- 
strated by other techniques (14-17). Since these results were regularly obtained 
TABLE  XII 
Mean Febrile Responses (°C) Induced by Supernates  sf Normal Blood Cells Incubated with either: 
(a) Sensitized  DLN or MLN Cells, with or without Antigen  (+ HSA/C); or (b) Supernates 
oJ Lymph Node Cells (from the Same Donors) Pre',riously Incubated 7z~ith or without Antigen 
(+ HSA/C) 
Normal blood ceils  (NBC)  -b 
DLN  MLN  Donor 
(day D HS) 
Cells  Supernate  Cells  Supernate 
(+ HSA/C)  (+ USA/C) 
°C  °C  °C  °C 
3  0.05/0.08  --  --  -- 
5  1.08/0.35  0.03/0.18  0.43/0.35  -- 
7  0.75/0.88  1.15/0.40  0.23/0.23  0.18/0.10 
12  0.73/0.48  0.80/0.35  0.58/0.33  0.55/0.28 
22  --  0.38/  --  --  0.70/0.48 
All figures are average of two recipients in single experiment. 
°C 
NBC  +  HSA (12)  0.10 
DLN +  HSA  (8)  0.15 
MLN  +  HSA  (8)  0.07 
NBC  +NMLN+HSA  (4)  0.19 
Number in parentheses =  number of recipients. 
with lymphocytes from DLN as early as 5 days after sensitization, and occasion- 
ally at 3 days (5 days before precipitating antibodies were detectable by Ouch- 
terlony and quantitative precipitin techniques)  it seems unlikely that activa- 
tion of the blood leukocytes was due to union of antigen and small amounts of 
antibody synthesized by  the lymphocytes during  incubation. 
The effective agent in activating normal blood cells to release EP in vitro ap- 
pears to be soluble, and was clearly detectable in supernatant fluids from viable 
it Addition of small amounts of endotoxin (filtered typhoid vaccine) to cellular suspensions 
of normal MLN that were subsequently disrupted by freeze-thawing, regularly evoked release 
of EP from normal blood cells incubated with these mixtures. It seems unlikely,  therefore, 
that disruption of cells  would inactivate this agent if it were initially present in DLN. E. ATKINS, J. D. FELDMAN,  L. FRANCIS, AND  E. I-IURSI{  1129 
lymph node lymphocytes previously incubated with antigen only. Similar results 
were obtained in a supplementary experiment with nonpyrogenic supernates of 
sensitized thoracic duct lymphocytes obtained 9 days after sensitization and 
previously incubated with specific antigen (BGG) (unpublished observations). 
By contrast, supernates of the same cells incubated alone or with BSA failed to 
activate normal blood cells. 
During the 1st wk after sensitization lymphocytes from DLN were generally 
more effective in  activating normal blood cells than were those from MLN. 
Since neither blood nor spleen~ which contain lymphocytes as well as pyrogen- 
producing cells, were capable of releasing EP when incubated with antigen at 
this early period, as shown in Table V, it seems probable that sensitized lymph- 
ocytes were present in significant numbers only in DLN at this early time. The 
lack of pyrogen-producing cells  in DLN  at 6-8  days appears  to explain the 
failure of antigen to release EP also from DLN. Later, at 10-20 days, spleen 
and blood, as well as DLN themselves, were activatable by antigen (having at 
this  time  presumably  both  sensitized  lymphocytes  and  pyrogen-producing 
cells). It therefore seems likely that sensitized lymphocytes, or antigen, migrate 
from the initial site of sensitization in the DLN to invade other tissues through- 
out the body. In support of this theory, lymphocytes from MLN after the 2nd 
wk were regularly effective in activating normal blood cells in the presence of 
antigen. 
By contrast, liver (containing few lymphocytes, but many Kupffer cells) 12 
or mesenteric lymph nodes alone (containing mostly small lymphocytes) failed 
to release EP after incubation with antigen in vitro, whether obtained early or 
late after sensitization. On the basis of these data, it seems reasonable to postu- 
late that during states of delayed hypersensitivity the lymphocyte, though in- 
capable of producing EP  itself, plays a  critical intermediate role in bringing 
about release of EP from these effector cells. 
The soluble agent released by sensitized lymphocytes was itself nonpyrogenic 
in the doses used to activate cells and appeared to require incubation of antigen 
with viable cells for its production. These properties suggest that the activator 
belongs  to  the  group  of  substances  collectively known  as  "lymphokines," 
agents produced by lymphocytes that are stimulated by various immunologic 
and nonimmunologic means and that possess such diverse physiologic activities 
as cytotoxicity, inhibition of macrophage migration, transformation of normal 
lbmaphocytes,  and others (3, 4,  18). 
On the other hand, despite clear evidence in other experimental fever models 
that antigen-antibody complexes are pyrogenic in vivo and will produce circu- 
lating EP (12), we were unable here and previously to activate normal blood 
leukocytes to generate EP in vitro with various combinations of antigen (DNP- 
BGG or BGG and, in unpublished studies, HSA) and antibodies, both in the 
12 The hepatocyte does not appear to produce EP (13). 1130  FEVER  ACCOMPANYING  DELAYED  HYPERSENSITIVITY 
zone of antigen excess and with precipitates of antigen and antibody. Such com- 
plexes presumably activate appropriate tissues in vivo, perhaps by phagocytosis 
or by release of mediators from injured tissues. 
If the lymphokine nature of this agent is confirmed by more direct techniques, 
these studies will have provided the first evidence for a truly endogenous acti- 
vator of leukocytes for pyrogen production,  13 as distinguished from such exog- 
enous agents as antigen-antibody complexes of heterologous serum proteins and 
activators of microbial origin. Although an activator of exudate leukocytes has 
been described from peritoneal fluids of rabbits infused with glycogen, the possi- 
bility that the effects were due, at least in part, to small amounts of contami- 
nating Gram-negative bacterial endotoxin could not be eliminated (20). 
For the reasons already stated, it seems unlikely that such nonspecific exoge- 
nous  activators are  responsible for the  findings presented here. Furthermore, 
since fever is so regularly associated with inflammation due to causes other than 
infection,  such  as  infarctions,  tumors,  acute  gouty arthritis,  and  sickle  cell 
crises, it is reasonable to believe that there must be other endogenous activators 
of appropriate cells for pyrogen production to account for the fevers appearing 
clinically in such situations. 
SUM'MARY 
Experiments have been carried out to investigate the possible role of the sensi- 
tized lymphocyte in mediating the fevers of delayed hypersensitivity. Rabbits 
were made delayed hypersensitive to one of several heterologous proteins  (bo- 
vine gamma globulin, bovine serum albumin, or human serum albumin) by foot- 
pad injection of antigen or antigen conjugated with dinitrophenol and incorpo- 
rated in complete Freund's adjuvant. At intervals after sensitization, various 
tissues were removed, and single cell suspensions were incubated overnight with 
either carrier protein or conjugate in vitro. Release of an endogenous  pyrogen 
(EP)  was  assayed by intravenous injection of the supernatant fluid into  un- 
sensitized rabbits. Of the tissues tested only those containing both lymphocytes 
and pyrogen-producing cells, blood, spleen, and draining lymph nodes, released 
detectable amounts of EP when incubated with antigen in vitro. Incubation of 
normal blood cells with specifically sensitized lymphocytes and antigen also re- 
sulted in significant release of pyrogen. Similarly, blood leukocytes released EP 
in vitro after mixture with  supernates  derived from incubation of sensitized 
lymphocytes and  antigen.  Cells  and  supernatant fluids from draining  lymph 
nodes were usually effective in activating normal blood leukocytes earlier after 
sensitization than were those from mesenteric lymph nodes, suggesting that such 
cells, or antigen, had migrated from the original site of sensitization. 
The activator was soluble, nonpyrogenic in the dosages tested, and required 
la Human (but not animal) leukocytes can be activated by certain endogenous  pyrogenic 
steroids in vitro (19). E.  ATKINS, J.  D.  FELDMAN, L.  FRANCIS, AND E.  HURSH  1131 
incubation of viable cells with specific antigen for its production. These proper- 
ties suggest that it may belong to the class of "lymphokines," biologically active 
agents released from lymphocytes that have been activated by immunologic or 
certain  nonimmunologic stimuli. 
The authors  would like to thank  Dr.  Phyllis  Bodel for helpful  editorial  criticism  and 
assistance with the statistical  evaluations. 
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